Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.46 |
| ▸ | ALPI | P09923 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | XIAP | P98170 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MPO | P05164 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | NOS3 | P29474 | 2/20 | 0.40 |
| ▸ | NOS1 | P29475 | 2/20 | 0.40 |
| ▸ | NOS2 | P35228 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8651825 | 0.76 | MAPT (0.46) | MAPTALDH1A1RECQLSLC7A5ALPI | |
| SCHEMBL1060620 | 0.75 | MAPT (0.67) | MAPTALDH1A1RECQLSLC7A5ALPI | |
| SCHEMBL828694 | 0.75 | MAPT (0.49) | MAPTALDH1A1RECQLSLC7A5ALPI | |
| SCHEMBL29550970 | 0.75 | MAPT (0.67) | MAPTALDH1A1RECQLSLC7A5ALPI | |
| SCHEMBL28738543 | 0.74 | SLC7A5 (0.50) | MAPTALDH1A1RECQLSLC7A5ALPI | |
| SCHEMBL6843793 | 0.74 | MAPT (0.48) | MAPTALDH1A1RECQLSLC7A5ALPI | |
| SCHEMBL23120097 | 0.74 | SLC7A5 (0.50) | MAPTALDH1A1RECQLSLC7A5ALPI | |
| SCHEMBL1162358 | 0.73 | MAPT (0.47) | MAPTALDH1A1RECQLSLC7A5ALPI | |
| SCHEMBL1520299 | 0.71 | MAPT (0.48) | MAPTALDH1A1RECQLSLC7A5ALPI | |
| SCHEMBL1996403 | 0.71 | MAPT (0.48) | MAPTALDH1A1RECQLSLC7A5ALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250354108-A1 | METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS | UNIV DANMARKS TEKNISKE (DK) | 2025-11-20 | — | — | US | disclosed |
| EP-4526426-A2 | METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS | Danmarks Tekniske Universitet (DK) | 2025-03-26 | — | — | EP | disclosed |
| WO-2023222879-A2 | METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS | DANMARKS TEKNISKE UNIVERSITET (DK) | 2023-11-23 | — | — | WO | disclosed |
| US-20220403428-A1 | YEAST CELLS AND METHODS FOR PRODUCTION OF TRYPTOPHAN DERIVATIVES | DANMARKS TEKNISKE UNIVERSITET (DK) | 2022-12-22 | — | — | US | disclosed |
| EP-4031671-A1 | YEAST CELLS AND METHODS FOR PRODUCTION OF TRYPTOPHAN DERIVATIVES | Danmarks Tekniske Universitet (DK) | 2022-07-27 | — | — | EP | disclosed |
| WO-2021052989-A1 | YEAST CELLS AND METHODS FOR PRODUCTION OF TRYPTOPHAN DERIVATIVES | DANMARKS TEKNISKE UNIVERSITET (DK) | 2021-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250354108-A1 | METHODS FOR PRODUCING MONOTERPENE INDOLE ALKALOIDS | INMT, KARS1, MIA3 | MAPT 3008/4885ALDH1A1 781/4885RECQL 2935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.